Isobutanol

Isobutanol

SCHEMBL7933372

CC(C)CO.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Isobutanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isobutanol SCHEMBL28999930 1.00 TSHR (0.90)
Isobutanol SCHEMBL28999937 1.00 TSHR (0.90)
Isobutanol SCHEMBL28276489 1.00
Isobutanol SCHEMBL28999942 1.00
Isobutanol SCHEMBL14062107 0.95
Isobutanol SCHEMBL2784475 0.95
Isobutanol SCHEMBL11800894 0.95 TSHR (1.00)
Isobutanol SCHEMBL969 0.95
Isobutanol SCHEMBL175952 0.95 TSHR (1.00)
Isobutanol SCHEMBL23672280 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321611-B Preparation method of cefixadine mother nucleus 湖北凌晟药业有限公司 2022-05-06 CN claimed
CN-112321611-A Preparation method of cefixadine mother nucleus 湖北凌晟药业有限公司 2021-02-05 CN claimed
CN-104860855-B A kind of preparation method of the methylmercapto butyric acid ester of 2 hydroxyl of the D of high-purity, L 4 宁夏紫光天化蛋氨酸有限责任公司 2017-06-16 CN claimed
CN-104860855-A Preparation method for high-purity D,L-2-hydroxyl-4-methylthiobutyrate CHONGQING UNISPLENDOUR CHEM CO 2015-08-26 CN claimed
CN-100494191-C Method for preparing 3- (imidazole-4-yl) pyridine DONGYANGGUANG PHARMACEUTICAL C (CN) 2009-06-03 CN claimed
CN-101029044-A Method for preparing 3- (imidazole-4-yl) pyridine DONGYANGGUANG PHARMACEUTICAL C (CN) 2007-09-05 CN claimed
EP-4721767-A1 ANTI-B7-H3 ANTIBODY OR FRAGMENT THEREOF, AND ANTIBODY DRUG CONJUGATE TARGETING B7-H3 Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. (CN) 2026-04-08 EP disclosed
EP-4674851-A1 PREPARATION METHOD FOR INDOLIZINO[1,2-B]QUINOLINE-10,13-DIONE DERIVATIVE Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2026-01-07 EP disclosed
US-20250059201-A1 CAMPTOTHECIN COMPOUND AND CONJUGATE THEREOF JIANGSU MABWELL HEALTH PHARMACEUTICAL R&D CO., LTD. (CN) 2025-02-20 US disclosed
WO-2024179564-A1 PREPARATION METHOD FOR INDOLIZINO[1,2-B]QUINOLINE-10,13-DIONE DERIVATIVE 江苏恒瑞医药股份有限公司 2024-09-06 WO disclosed
CN-113563365-B Preparation method of 7-amino-3-methoxy-4-cephalosporanic acid 华中药业股份有限公司 2024-05-28 CN disclosed
US-20220211694-A1 QUINOLINE DERIVATIVES FOR TREATMENT OF HEAD AND NECK CANCER CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-07-07 US disclosed
CN-112759602-B Method for preparing 7-ANCE (carbacephem nucleus) 湖北凌晟药业有限公司 2022-07-01 CN disclosed
US-6048677-A PHOTOGRAPHIC FILMS, SUPPORTS WITH LIGHT SENSITIVE EMULSIONS, RADIATION TRANSPARENT, MAGNETISM LAYER AND SUPERIMPOSING SIDES ON SUPPORTS EASTMAN KODAK COMPANY (US) 2000-04-11 US disclosed
US-5364824-A Oxidation HUNTSMAN SPECIALTY CHEMICALS CORPORATION (US) 1994-11-15 US disclosed
CN-1091998-A Be used to prepare the catalyst of the promoter elements that contains vanadium-phosphorus oxide and selection of maleic anhydride MONSANTO CO (US) 1994-09-14 CN disclosed
WO-1994013401-A1 CATALYSTS FOR THE PRODUCTION OF MALEIC ANHYDRIDE CONTAINING VANADIUM-PHOSPHORUS OXIDE WITH SELECTED PROMOTER ELEMENTS HUNTSMAN SPECIALTY CHEMICALS CORPORATION (US) 1994-06-23 WO disclosed
EP-0265668-A1 Process for the preparation of a Diisocyanate BAYER AG (DE) 1988-05-04 EP disclosed
US-4731093-A Process for fixing pigments on fiber materials and sheetlike structures HOECHST AKTIENGESELLSCHAFT (DE) 1988-03-15 US disclosed
EP-0179331-A2 Process for fixing pigments on fibrous materials and structures having a flat surface HOECHST AKTIENGESELLSCHAFT (DE) 1986-04-30 EP disclosed